A new report details that China purchased a massive amount of testing equipment for viruses like COVID-19 months before the WHO filed official reports of the outbreak in December 2019. The testing equipment in question is what is known as a PCR test or polymerase chain reaction test. These tests can be used to detect viruses in humans or animals.
"Public policymakers have chosen to force a 'one size fits all' treatment strategy, resulting in needless illness and death, rather than upholding fundamental concepts of the individualized, personalized approach to patient care which is proven to be safe and more effective."
In 2020, at the World Economic Forum, David Solomon, the CEO of Goldman Sachs, proclaimed that the investment firm wouldn’t take corporations public unless they had at least one “diverse” member on their board.